canada semaglutide patent expiry Walk-In Maps Timeline Behind Canada's G7-First Generic As patents on weight-loss drugs

While hailed as a 'gamechanger' in the fight against bulging waistlines, the jabs have notable downsides

Standard BMI categories are: Underweight: BMI less than 18.5 kg/m2 Healthy weight: BMI of 18.5 to less than 25 kg/m2 Overweight: BMI of 25 to less than 30 kg/m2 Obesity: BMI of 30 kg/m2 or more Class 1 obesity: 30 to less than 35 kg/m2 Class 2 obesity: 35 to less than 40 kg/m2 Class 3 obesity: 40 kg/m2 or more FDA-approved weight loss drugs are typically prescribed for adults with obesity (BMI of 30 or more) or overweight (BMI of 27 or more) plus a weight-related medical condition

We offer comprehensive support throughout this journey, ensuring approvals and reducing overall hassles

This applies when impairment cannot be proven